Showing results (21-30 of 37) with videos related to
Sort By:
Pageof 4
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 29, 2025
Estimating the economic consequences of leveraging the novel cobas® HIV-1/HIV-2 Qualitative NAT Test in routine HIV testingS Pinar Bilir, Pallavi Krishnamurthy, James K Karichu, et al.The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|March 31, 2010
The association between noncancer pain, cognitive impairment, and functional disability: an analysis of the Canadian study of health and agingJoseph W Shega, Debra K Weiner, Judith A Paice, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 19, 2024
Cost-Effectiveness of Axicabtagene Ciloleucel for Adult Patients With Relapsed or Refractory Follicular Lymphoma in the United StatesOlalekan O Oluwole, Markqayne D Ray, Katherine L Rosettie, et al.Head & Neck|February 6, 2004
Prioritizing treatment outcomes: head and neck cancer patients versus nonpatientsMarcy A List, Judith Lee Rutherford, John Stracks, et al.Archives of Otolaryngology--Head & Neck Surgery|October 22, 2008
Characteristics associated with swallowing changes after concurrent chemotherapy and radiotherapy in patients with head and neck cancerJoseph K Salama, Kerstin M Stenson, Marcy A List, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2005
Phase II trial of gefitinib 250 mg daily in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neckEzra E W Cohen, Madeleine A Kane, Marcy A List, et al.The New England Journal of Medicine|February 11, 2005
Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapyGillian D Sanders, Ahmed M Bayoumi, Vandana Sundaram, et al.Journal of the National Cancer Institute|September 18, 2003
Is patient travel distance associated with survival on phase II clinical trials in oncology?Elizabeth B Lamont, Davinder Hayreh, Kate E Pickett, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2003
Induction chemotherapy followed by concomitant TFHX chemoradiotherapy with reduced dose radiation in advanced head and neck cancerDaniel J Haraf, Fred R Rosen, Kerstin Stenson, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2006
High survival and organ function rates after primary chemoradiotherapy for intermediate-stage squamous cell carcinoma of the head and neck treated in a multicenter phase II trialEzra E W Cohen, Daniel J Haraf, Marcy A List, et al.Pageof 4